Based on these findings, omentin was suggested as dual-purpose biomarker in CRC: a state marker reflecting disease presence and biological aggressiveness, and a prognostic tool for stratifying risk of early postoperative relapse and death, potentially informing surveillance and adjuvant treatment decisions [56]. Here, ITLN1 is linked to colorectal carcinoma.